Cross reactivity of commercial anti-dengue immunoassays in patients with acute Zika virus infection
about
Zika Virus: Recent Advances towards the Development of Vaccines and Therapeutics.Congenital Zika syndrome: an epidemic of neurologic disability.Compensating for cross-reactions using avidity and computation in a suspension multiplex immunoassay for serotyping of Zika versus other flavivirus infections.Development and evaluation of a rapid molecular diagnostic test for Zika virus infection by reverse transcription loop-mediated isothermal amplification.Specific detection of dengue and Zika virus antibodies using envelope proteins with mutations in the conserved fusion loop.Zika virus displacement by a chikungunya outbreak in Recife, Brazil.High Zika Virus Seroprevalence in Salvador, Northeastern Brazil Limits the Potential for Further Outbreaks.Metagenomic analysis reveals Hepatitis A virus in suspected yellow fever cases in Brazil.Zika Virus Testing and Outcomes during Pregnancy, Florida, USA, 2016.Chikungunya, Dengue, and Zika in Immunocompromised Hosts.Examining the potential for South American arboviruses to spread beyond the New World.Implications of Zika virus and congenital Zika syndrome for the number of live births in Brazil.Diagnostic performance of commercial IgM and IgG enzyme-linked immunoassays (ELISAs) for diagnosis of Zika virus infection.
P2860
Q32183208-8985EC33-619C-44D5-9F91-7A2501E7BE5DQ38156726-9930A3A6-E108-4F63-A196-15DE396E1F61Q39416470-A9F35D38-1046-4A7F-AF74-09108309631BQ42677247-2D452011-5419-437F-80F2-FE20258FBF5CQ43046666-A7E8BE7B-E0BF-4443-A193-57E6F5810484Q43046780-582550AC-B2CD-4FA3-8511-95F5967F169EQ44843559-3C4AA3A2-2F3B-497A-96A3-D369479DC7A7Q45323733-252634AA-EE9D-4392-B100-D70C9F7FF455Q47558432-F7758086-D73E-47CB-9A1C-21BD54AD3F43Q51336222-B75EBD9B-1B32-450B-974F-128B46784E50Q55084452-37D12C85-6417-4E29-82BA-D971891C844BQ55284316-AFF18824-C6FC-4887-A93B-218B3D5B3B1EQ55710677-241BFB73-C749-4A5C-9E13-D353E4E3843F
P2860
Cross reactivity of commercial anti-dengue immunoassays in patients with acute Zika virus infection
description
2017 nî lūn-bûn
@nan
2017 թուականի Փետրուարին հրատարակուած գիտական յօդուած
@hyw
2017 թվականի փետրվարին հրատարակված գիտական հոդված
@hy
2017年の論文
@ja
2017年論文
@yue
2017年論文
@zh-hant
2017年論文
@zh-hk
2017年論文
@zh-mo
2017年論文
@zh-tw
2017年论文
@wuu
name
Cross reactivity of commercial ...... ith acute Zika virus infection
@ast
Cross reactivity of commercial ...... ith acute Zika virus infection
@en
type
label
Cross reactivity of commercial ...... ith acute Zika virus infection
@ast
Cross reactivity of commercial ...... ith acute Zika virus infection
@en
prefLabel
Cross reactivity of commercial ...... ith acute Zika virus infection
@ast
Cross reactivity of commercial ...... ith acute Zika virus infection
@en
P2093
P2860
P921
P356
P1476
Cross reactivity of commercial ...... ith acute Zika virus infection
@en
P2093
Angela A. Costa
Camila Malta Romano
Claudio Sergio Pannuti
Marta Inenami
Nathalia C. Santiago Souza
Rosangela MG da Silva
Walter M Figueiredo
P2860
P356
10.1002/JMV.24789
P577
2017-02-01T00:00:00Z